Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,601,899
-
Share change
-
+719,694
-
Total reported value
-
$3,085,693,628
-
Put/Call ratio
-
116%
-
Price per share
-
$165.86
-
Number of holders
-
169
-
Value change
-
+$69,994,780
-
Number of buys
-
103
-
Number of sells
-
81
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q3 2015
As of 30 Sep 2015,
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,601,899 shares.
The largest 10 holders included
FMR LLC, AMERIPRISE FINANCIAL INC, Capital World Investors, Carmignac Gestion, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, FIRST TRUST ADVISORS LP, BlackRock Institutional Trust Company, N.A., and FRED ALGER MANAGEMENT INC.
This page lists
169
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.